Table 1.
Type | Mechanisms | Examples | |
---|---|---|---|
Intrinsic mechanisms | Adaptive resistance | Activation of signaling pathways | PI3K WNT/β-catenin IFN-γ |
Upregulation of constitutive PD-L1 expression | |||
Epigenetic variations | KDM5B | ||
Loss of tumor antigen expression | Low mutation burden | ||
Acquired resistance | |||
Downregulation of tumor antigen presentation | The function defects of: Proteasome subunits transporters MHC itself β-2-microglobulin (B2M) |
||
Changes of T cells functional phenotype | |||
The mutations of tumor cells | JAK1/JAK2 B2M |
||
Extrinsic mechanisms |
Inhibitory immune checkpoints | CTLA-4 PD-1 LAG-3 VISTA |
|
T cell exhaustion and phenotypic changes | |||
immunosuppressive cells | TAMs Tregs |
||
The release of cytokine and metabolite | CSF-1 Adenosine tryptophan metabolites |